EUVIMEDEUVIMED entdecken
Crossref

SPON2 acts as a tumor promoter in HR-positive/HER2-negative breast cancer by regulating β-catenin signaling

Gu-Yue Liu, Dong-Ping Huang, Can Ge, Xiao-Yu Li, Fei Chen, Jia-Shu Fan, Huan-Ping Tu

Clinical Breast Cancer · 2026

DOI: 10.1016/j.clbc.2025.07.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Gu-Yue Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shanghai Putuo People's Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: guyue065…. Hauptthemen laut MEDLINE: Breast Neoplasms, beta Catenin, Extracellular Matrix Proteins. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast Neoplasmsbeta CateninExtracellular Matrix ProteinsHumansFemaleAnimalsCell ProliferationMiceErb-b2 Receptor Tyrosine KinasesCell MovementGene Expression Regulation, NeoplasticCell Line, TumorXenograft Model Antitumor AssaysReceptors, ProgesteroneReceptors, EstrogenMice, NudeMice, Inbred BALB CSignal TransductionMiddle AgedR-Spondins

Stichwörter der Autor:innen

MigrationProliferation

Substanzen

beta CateninErb-b2 Receptor Tyrosine KinasesExtracellular Matrix ProteinsERBB2 protein, humanCTNNB1 protein, humanRspo2 protein, humanReceptors, ProgesteroneReceptors, EstrogenR-Spondins

Autor:innen und Institutionen

  • Department of General Surgery, Shanghai Putuo People's Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: guyue0652@hhu.edu.cn.
  • Department of General Surgery, Shanghai Putuo People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Department of General Surgery, Shanghai Putuo People's Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: 18721033022@163.com.

Zitieren

APA

Liu, G. Y., Huang, D. P., Ge, C., Li, X. Y., Chen, F., Fan, J. S., & Tu, H. P. (2026). SPON2 acts as a tumor promoter in HR-positive/HER2-negative breast cancer by regulating β-catenin signaling. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.07.030

Vancouver

Liu GY, Huang DP, Ge C, Li XY, Chen F, Fan JS, et al. SPON2 acts as a tumor promoter in HR-positive/HER2-negative breast cancer by regulating β-catenin signaling. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2025.07.030

BibTeX
@article{Liu2026,
  author = {Liu, Gu-Yue and Huang, Dong-Ping and Ge, Can and Li, Xiao-Yu and Chen, Fei and Fan, Jia-Shu and Tu, Huan-Ping},
  title = {SPON2 acts as a tumor promoter in HR-positive/HER2-negative breast cancer by regulating β-catenin signaling},
  journal = {Clinical Breast Cancer},
  year = {2026},
  doi = {10.1016/j.clbc.2025.07.030}
}
Kostenlos starten →